BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12816733)

  • 21. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
    Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
    Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression in lung adenocarcinomas of smokers and nonsmokers.
    Powell CA; Spira A; Derti A; DeLisi C; Liu G; Borczuk A; Busch S; Sahasrabudhe S; Chen Y; Sugarbaker D; Bueno R; Richards WG; Brody JS
    Am J Respir Cell Mol Biol; 2003 Aug; 29(2):157-62. PubMed ID: 12600827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
    Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
    Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells.
    Chen JT; Lin TS; Chow KC; Huang HH; Chiou SH; Chiang SF; Chen HC; Chuang TL; Lin TY; Chen CY
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):264-73. PubMed ID: 16254251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
    Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
    Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
    Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
    Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer.
    Chen Y; Pacyna-Gengelbach M; Ye F; Knösel T; Lund P; Deutschmann N; Schlüns K; Kotb WF; Sers C; Yasumoto H; Usui T; Petersen I
    J Pathol; 2007 Mar; 211(4):431-8. PubMed ID: 17236181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
    Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
    Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma.
    Aviel-Ronen S; Lau SK; Pintilie M; Lau D; Liu N; Tsao MS; Jothy S
    Mod Pathol; 2008 Jul; 21(7):817-25. PubMed ID: 18469798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
    Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
    J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPP1-mediated tumor suppression requires activation of STAT1 pathways.
    Elahi A; Zhang L; Yeatman TJ; Gery S; Sebti S; Shibata D
    Int J Cancer; 2008 Apr; 122(7):1567-72. PubMed ID: 18059030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.